Omega Therapeutics Newsroom

Omega Therapeutics Analyst Ratings

BenzingaAug 15 07:12 ET

Omega Therapeutics Price Target Maintained With a $12.00/Share by Wedbush

Dow JonesAug 7 10:51 ET

Omega Therapeutics Analyst Ratings

BenzingaAug 7 06:52 ET

Omega Therapeutics Analyst Ratings

BenzingaJun 18 09:06 ET

Omega Therapeutics Analyst Ratings

BenzingaMay 13 06:37 ET

Buy Rating Reaffirmed for Omega Therapeutics on Strong Clinical and Financial Performance

TipRanksMay 13 06:35 ET

Analysts' Top Healthcare Picks: Fresenius Medical Care AG & Co. KGaA (GB:0H9X), Omega Therapeutics (OMGA)

TipRanksMay 8 05:05 ET

Omega Therapeutics Analyst Ratings

BenzingaMay 7 09:07 ET

Buy Rating Affirmed for Omega Therapeutics Amid Strong Financials and Promising OTX-2002 Clinical Trials

TipRanksMay 6 22:50 ET

Analysts Conflicted on These Healthcare Names: Annovis Bio (ANVS), Gilead Sciences (GILD) and Omega Therapeutics (OMGA)

TipRanksApr 30 06:35 ET

Omega Therapeutics Analyst Ratings

BenzingaApr 30 06:20 ET

Omega Therapeutics Analyst Ratings

BenzingaApr 3 11:28 ET

Piper Sandler Reiterates Overweight on Omega Therapeutics, Lowers Price Target to $9

BenzingaApr 3 11:28 ET

Omega Therapeutics (OMGA) Receives a Buy From Piper Sandler

TipRanksApr 3 07:11 ET

Omega Therapeutics Analyst Ratings

BenzingaApr 1 08:24 ET

Piper Sandler Remains a Buy on Omega Therapeutics (OMGA)

TipRanksFeb 7 08:18 ET

Buy Rating on Omega Therapeutics: Innovative Obesity Treatment Through Strategic Novo Nordisk Collaboration

TipRanksJan 5 06:30 ET

Wedbush Reiterates Outperform on Omega Therapeutics, Maintains $12 Price Target

BenzingaJan 4 13:57 ET

Omega Therapeutics Analyst Ratings

BenzingaJan 4 13:56 ET

Piper Sandler Sticks to Their Buy Rating for Omega Therapeutics (OMGA)

TipRanksNov 14, 2023 07:36 ET